Diaceutics Future Growth

Future criteria checks 4/6

Diaceutics is forecast to grow earnings and revenue by 43.3% and 18.8% per annum respectively while EPS is expected to grow by 26.9% per annum.

Key information

43.3%

Earnings growth rate

26.9%

EPS growth rate

Life Sciences earnings growth18.8%
Revenue growth rate18.8%
Future return on equityn/a
Analyst coverage

Low

Last updated26 Sep 2023

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

OTCPK:DIUX.F - Analysts future estimates and past financials data (GBP Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2025380184
12/31/202430-2-335
12/31/202324-2-425
6/30/2023220-33N/A
3/31/2023210-14N/A
12/31/202220105N/A
9/30/2022180N/AN/AN/A
6/30/2022160-33N/A
3/31/2022150-42N/A
12/31/2021141-51N/A
9/30/2021140N/AN/AN/A
6/30/202113-1-60N/A
3/31/2021130-60N/A
12/31/2020130-60N/A
9/30/2020142-51N/A
6/30/2020143-41N/A
3/31/2020142-40N/A
12/31/2019130-4-1N/A
9/30/2019120-30N/A
6/30/2019110-20N/A
3/31/2019110-2-1N/A
12/31/2018101-2-1N/A
12/31/20177112N/A
12/31/201651N/A1N/A
12/31/201510N/AN/AN/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: DIUX.F's forecast earnings growth (43.3% per year) is above the savings rate (2.2%).

Earnings vs Market: DIUX.F's earnings (43.3% per year) are forecast to grow faster than the US market (14.9% per year).

High Growth Earnings: DIUX.F's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: DIUX.F's revenue (18.8% per year) is forecast to grow faster than the US market (8.1% per year).

High Growth Revenue: DIUX.F's revenue (18.8% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if DIUX.F's Return on Equity is forecast to be high in 3 years time


Discover growth companies